Schedule 13G Filing by Integrated Core Strategies (US) LLC and Others for Quoin Pharmaceuticals Ltd.

Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly filed a Schedule 13G with the SEC, disclosing their beneficial ownership of Ordinary Shares in Quoin Pharmaceuticals Ltd. The filing indicates that these entities collectively own approximately 9% of the company's Ordinary Shares, totaling 1,901,585 shares. The shares are held by entities subject to voting control and investment discretion by Millennium Management LLC and other investment managers controlled by Millennium Group Management LLC and Israel A. Englander. The filing is made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934. The joint filing agreement confirms that the Schedule 13G is filed on behalf of each of the persons and entities named in the agreement.